A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome

NCT02701985 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Sjogren's Syndrome

Interventions

DRUG: Placebo
DRUG: RO5459072

Sponsor

Hoffmann-La Roche